News

Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program
The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundation ...
Medical Dialogues2d
Fidanacogene Elaparvovec Gene Therapy Demonstrates Long-Term Safety and Efficacy in Hemophilia B Over 6 Years: Study
Australia: In a significant development for Hemophilia B treatment, a multi-year follow-up study has shown that a single ...
Beyond bleeding: Understanding more about Hemophilia and the treatments available
Hemophilia impairs the body's capacity to form blood clots, a process essential for haemostasis following bleeding. This ...
Rising Kashmir19h
Hemophilia patients blame ‘testing hurdles’ for drug shortage at GMC Sgr day care centre
Haemophilia patients at GMC Srinagar’s day care centre on Thursday said life saving clotting drugs remain unavailable, ...
Genetics of hemophilia: Why mutations matter more than ever in diagnosis and treatment
Hemophilia, a rare inherited bleeding disorder, is primarily caused by mutations in specific genes that impair the body’s ...
Onlymyhealth8d
What Happens When Blood Doesn’t Clot? Know The Science Behind Factor Deficiencies In Hemophilia
If blood clotting is affected for a longer period of time it can cost your life! Read this article to understand more about ...
World Hemophilia Day: Equity in bleeding disorder care isn’t optional — it’s long overdue
According to estimates by the World Federation of Hemophilia, nearly 80% of hemophilia cases in India remain undiagnosed, ...
Taiwan News11d
Japan Hemophilia Treatment Market Projected to Reach US$ 937.37 Million by 2033, Growing at a CAGR of 6.16%
The hemophilia treatment market in Japan is expected to witness steady growth during the forecast period, with a projected CAGR of 6.16% from 2025 to 2033. By the end of this period, the market is ...
Sobi and Sanofi's Foundation S extend partnership with the World Federation of Hemophilia Humanitarian Aid Program
Sobi® (STO: SOBI) together with the World Federation of Hemophilia (WFH) and Sanofi, through its philanthropic organisation Foundation S, announced the signing of a contract providing support to the ...